Manchester Urology Surgeons offer the UroLift® procedure for male urinary symptoms. The UroLift® system received Interventional Procedures Guidance from NICE in January 2014.
The UroLift® is a minimally invasive treatment option for patients with urinary symptoms secondary to BPH. This treatment directly opens a channel in the anterior of the prostatic urethra by retracting the obstructing prostatic lobes without cutting, heating or removing prostate tissue. The prostatic lobes are retracted by using small permanent implants. Clinical data has shown the following:
- Rapid symptom relief as early as 2 weeks post-procedure with only mild urinary discomfort post-procedure during the recovery period
- Successful prostatic urethral opening is endoscopically confirmed immediately post-procedure
- Majority of patients do not require post treatment catheterization
- There have been no reports of new onset of sexual dysfunction, retrograde ejaculation or permanent erectile dysfunction following treatment with the UroLift® System.
Patients most suitable for this new treatment:
- Patients with prostates 80cc and smaller, not in retention, with little to no median lobe and no prostate cancer
- Patients that have tried drug therapies but can’t tolerate the side effects or are no longer obtaining any benefit from drug therapy
- Patients with significant urinary symptoms that possibly need surgical intervention but don’t want to lose sexual function
- Patients that want a minimally invasive procedure with a faster recovery time than conventional procedures
For more information contact Manchester urology on 01614957796 or download the patient information sheet.